Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05691972 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 225
- Enrollment target
NCT05691972 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 225 participants.
The verdict
NCT05691972, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
Study Summary
This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.
Interventions
- DEVICE Restylane Contour
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2023-03-14 |
| Est. Completion | 2024-12-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05691972
The ClinicalTrials.gov registry entry for NCT05691972 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Restylane Contour is the first listed.
NCT05691972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05691972 about?
NCT05691972 is a clinical study titled "Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing". This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.
What is the current status of trial NCT05691972?
This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2023-03-14. Estimated completion is 2024-12-11.
What interventions are being tested in trial NCT05691972?
The interventions under investigation include: Restylane Contour (DEVICE).
Who is sponsoring clinical trial NCT05691972?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.